Vietnam Investment Review on MSN
PolyU creates antibody for liver cancer treatment
HONG KONG SAR - Media OutReach Newswire - 3 February 2026 - Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become increasingly common in ...
Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...
This comprehensive 2026 report on Gelatine Sculpt provides an in-depth examination of the Gelatine Sculpt supplement's ...
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...
NMD Pharma is accelerating ignaseclant’s clinical development in CMT alongside multiple near-term clinical catalysts across its neuromuscular pipeline, with Phase 2 studies in spinal muscular atrophy ...
Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...
Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...
Improvements in public health have allowed humankind to survive to older ages than ever before, but, for many people, these ...
Improvements in public health have allowed humankind to survive to older ages than ever before, but, for many people, these ...
Aging is inevitable, but getting old is a choice. And while we can’t stop the clock, we can make the most of the time remaining. Neurogan can help keep you on the right path.
The ADP/ATP carrier AAC3 was further examined as a structural case study, based on comparative modeling and structure–function analyses to illustrate how carrier conformational features may be ...
Ryan Allen, an assistant professor of physiology and cell biology at UAMS, will share a current project from his lab dedicated to developing a drug-responsive mouse model of atherosclerosis, a disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results